These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6279383

  • 1. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
    Dumoulin J.
    Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
    [No Abstract] [Full Text] [Related]

  • 2. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A, McCans J, Willan AR, Ford PM.
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [Abstract] [Full Text] [Related]

  • 3. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
    Baro F, Malfroid M, Waegemans T, Cox JP.
    Pharmatherapeutica; 1985 Aug; 4(6):399-404. PubMed ID: 3001778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
    Rodeheffer RJ, Rommer JA, Wigley F, Smith CR.
    N Engl J Med; 1983 Apr 14; 308(15):880-3. PubMed ID: 6339921
    [No Abstract] [Full Text] [Related]

  • 7. [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].
    Madsen JL, Hvidt S.
    Ugeskr Laeger; 1984 Sep 03; 146(36):2695-7. PubMed ID: 6393495
    [No Abstract] [Full Text] [Related]

  • 8. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L, Hart LL.
    Drug Intell Clin Pharm; 1984 Mar 03; 18(3):213-4. PubMed ID: 6365494
    [No Abstract] [Full Text] [Related]

  • 9. Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
    Mahler F, Schneider E, Gallino A, Bollinger A.
    Vasa; 1987 Mar 03; 16(4):381-5. PubMed ID: 2827398
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
    Gregoratti L, Redaelli G, Limido P, Ghiringhelli L.
    Clin Ter; 1982 Sep 30; 102(6):607-19. PubMed ID: 6291844
    [No Abstract] [Full Text] [Related]

  • 11. Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon.
    Nahir AM, Schapira D, Scharf Y.
    Isr J Med Sci; 1986 Feb 30; 22(2):139-42. PubMed ID: 3081460
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G, Scali G, Casa B, Nonis E.
    Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    Vasa Suppl; 1987 Aug 31; 18():68-70. PubMed ID: 3299818
    [No Abstract] [Full Text] [Related]

  • 14. Intermittent claudication: Suloctidil v.s. placebo treatment.
    Holm J, Lindblad L, Scherstén T, Suurkula M.
    Vasa; 1984 Aug 31; 13(2):175-8. PubMed ID: 6331019
    [No Abstract] [Full Text] [Related]

  • 15. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G, Majorana M.
    Clin Ter; 1983 Mar 15; 104(5):375-81. PubMed ID: 6303677
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.
    Sunderland GT, Belch JJ, Sturrock RD, Forbes CD, McKay AJ.
    Clin Rheumatol; 1988 Mar 15; 7(1):46-9. PubMed ID: 3044673
    [Abstract] [Full Text] [Related]

  • 18. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
    Chieffo C, Postiglione A, Tritto C, Mancini M.
    Curr Med Res Opin; 1984 Mar 15; 9(3):147-52. PubMed ID: 6094103
    [Abstract] [Full Text] [Related]

  • 19. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J, Kraus A, González-Amaro R, Alarcón-Segovia D.
    J Rheumatol; 1984 Jun 15; 11(3):362-4. PubMed ID: 6376801
    [Abstract] [Full Text] [Related]

  • 20. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M, Polaszewska-Muszyńska M, Ukleja-Adamowicz M, Rewakowicz M, Guzowska M, Marunowska A, Jundziłł W, Wodyńska T, Ruchalski M, Strzelecki A.
    Kardiol Pol; 1987 Jun 15; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.